Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Roche To Restructure | Contract Pharma

What are you searching for?

Sign in
Breaking News

Roche To Restructure

Roche has launched a group-wide Operational Excellence initiative aimed at “adapting to cost structures and accelerating productivity improvements.” The initiative is scheduled for implementation during 2011 and 2012.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roche has launched a group-wide Operational Excellence initiative aimed at “adapting to cost structures and accelerating productivity improvements.” The initiative is scheduled for implementation during 2011 and 2012.

Analysts speculate that the company will cut between $2 and $3 billion from its cost structure, which could result from eliminating part of its sales force and reducing overlap with U.S. unit Genentech. The need to reduce costs stems from pipeline setbacks, a narrower window for Avastin, and the health-care overhauls in the U.S. and Europe.

During the next few months, all parts of the organization will review their respective structures and processes. Decisions on the restructuring and the potential impact on staffing levels are expected before the end of the year.

Severin Schwan, chief executive officer of Roche, said, “We have launched this initiative from a position of strength. By contrast with many of our competitors, we are only marginally affected by patent expiries. Furthermore, despite the recent setbacks, we have one of the strongest R&D product pipelines in the industry. We will focus our resources towards investments that will drive innovation and ensure the company’s long-term success, while at the same time protecting our profitability so as to safeguard our financial flexibility.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters